Dermata Therapeutics, Inc. (DRMA)

NASDAQ: DRMA · IEX Real-Time Price · USD

0.337

-0.019 (-5.34%)

At close: Apr 26, 2024, 2:52 PM

0.357

+0.020 (5.93%)

After-hours: Apr 26, 2024, 5:00 PM EDT

Dermata Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	3.97	4.02	4.4	1.57	1.85
Research & Development	4.07	5.65	3.46	1.61	2.62
Operating Expenses	8.04	9.67	7.86	3.17	4.47
Operating Income	-8.04	-9.67	-7.86	-3.17	-4.47
Interest Expense / Income	0	0	0.05	0.2	0.25
Other Expense / Income	-0.25	-0.06	-	-0.13	-
Pretax Income	-7.79	-9.61	-7.9	-3.24	-4.72
Net Income	-7.79	-9.61	-7.9	-3.24	-4.72
Preferred Dividends	0	0	2.56	0	0
Net Income Common	-7.79	-9.61	-10.46	-3.24	-4.72
Shares Outstanding (Basic)	3	1	0	0	0
Shares Outstanding (Diluted)	3	1	0	0	0
Shares Change	323.42%	156.86%	125.13%	-	-
EPS (Basic)	-2.67	-13.92	-38.88	-27.04	-39.52
EPS (Diluted)	-2.67	-13.92	-38.88	-27.04	-39.52
Free Cash Flow	-6.41	-8.83	-5.69	-4.03	-3.92
Free Cash Flow Per Share	-2.19	-12.79	-21.17	-33.73	-32.84
EBITDA	-7.79	-9.61	-7.86	-3.04	-4.47
Depreciation & Amortization	0	0	0	0	0
EBIT	-7.79	-9.61	-7.86	-3.04	-4.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).